Eli Lilly and Novo Nordisk have come to an agreement with the Trump Administration to lower the costs of their landmark glucagon-like peptide-1 (GLP-1) receptor agonist drugs tirzepatide (Zepbound, Mounjaro
Retatrutide is not licensed by the MHRA and cannot be legally purchased or prescribed in the UK outside of an authorised clinical trial
Emerging options worth knowing about The GLP-1 landscape is expanding rapidly
Cost is unlikely to be a deciding factor
Alcohol in the form of wine, beer, or liquor, which can irritate the stomach, cause changes to blood sugar, and make side effects worse
Possible adverse reactions may include: To minimize risks, adhere to essential safety protocols when purchasing, handling, and administering ipamorelin